Dictionary

The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.

51–100 of 332 terms matching “Economic Evaluation”

C

Cataract EconomicsCataract Surgery Economics, Lens Replacement Economics
The application of health economic evaluation to cataract surgery, one of the world's most commonly performed procedures, comparing techniques and lens choices.
Chagas Disease EconomicsChagas Economics, American Trypanosomiasis Economics
The application of health economic evaluation to Chagas disease, a parasitic infection endemic to Latin America causing serious cardiac and gastrointestinal complications untreated.
Chemotherapy EconomicsChemo Economics, Cytotoxic Therapy Economics
The application of health economic evaluation to cytotoxic cancer treatment regimens, comparing different protocols and their combination with newer treatment modalities.
Chikungunya EconomicsCHIKV Economics, Chikungunya Fever Economics
The application of health economic evaluation to chikungunya, a mosquito-borne viral infection causing severe and sometimes prolonged joint pain.
Child Mental Health EconomicsPaediatric Mental Health Economics, Child Psychiatry Economics
The application of health economic evaluation to mental health conditions and interventions specific to children, spanning developmental, behavioural, and emotional disorders.
Cholecystitis EconomicsGallbladder Inflammation Economics, Cholecystitis Cost Analysis
The application of health economic evaluation to gallbladder inflammation, comparing timing and approach to surgical removal against conservative medical management.
Chronic Disease EconomicsChronic Illness Economics, NCD Economics
The application of health economic evaluation to long-lasting, non-communicable conditions such as diabetes and heart disease, typically using long time horizons.
Chronic Pain EconomicsPersistent Pain Economics, Chronic Pain Cost Analysis
The application of health economic evaluation to chronic pain, comparing medication, physical therapy, interventional procedures, and multidisciplinary pain management.
Clinical PracticeClinical Care, Medical Practice
In health economics, the delivery of care to patients by health professionals, the real-world setting whose effectiveness, costs and variation health economic evaluation seeks to inform.
Clostridium EconomicsC. difficile Economics, CDI Economics
The application of health economic evaluation to Clostridium infections, notably Clostridioides difficile, a common and costly healthcare-associated diarrhoeal illness.
Coeliac Disease EconomicsCeliac Disease Economics, Gluten Enteropathy Economics
The application of health economic evaluation to coeliac disease, an autoimmune condition triggered by gluten, covering diagnosis and lifelong gluten-free diet cost.
Colorectal EconomicsColorectal Disease Economics, Bowel Economics
The application of health economic evaluation to conditions affecting the colon and rectum, spanning cancer screening, inflammatory bowel disease, and diverticular disease.
Communication PlanComms Plan, Evidence Dissemination Plan
A strategic document outlining how health economic evaluation results and clinical evidence will be communicated to payers, clinicians, and patients.
Community Mental Health EconomicsCommunity Psychiatry Economics, CMH Economics
The application of health economic evaluation to community-based mental health service delivery, comparing cost and outcomes against institutional psychiatric care.
Companion Diagnostic EconomicsCompanion Diagnostic Cost-Effectiveness, CDx Economics
The application of health economic evaluation to diagnostic tests developed alongside a specific targeted cancer therapy, identifying patients likely to benefit.
ComparatorControl Intervention, Reference Arm
The alternative intervention, treatment, or strategy against which a new option is evaluated in an economic evaluation.
Comparator SelectionComparator Choice, Choice of Comparator
The process of identifying the appropriate existing treatment against which a new technology will be evaluated within an economic evaluation.
COPD EconomicsChronic Obstructive Pulmonary Disease Economics, COPD Cost-Effectiveness
The application of health economic evaluation to chronic obstructive pulmonary disease, comparing inhaled medication, pulmonary rehabilitation, and severe-case interventions.
Coronary Artery Disease EconomicsCAD Economics, Ischaemic Heart Disease Economics
The application of health economic evaluation to narrowed or blocked coronary arteries, comparing medication, percutaneous intervention, and surgical revascularisation.
Coronary Disease EconomicsCoronary Heart Disease Economics, CHD Economics
The application of health economic evaluation to conditions from narrowed or blocked coronary arteries, covering prevention, diagnosis, and treatment.
Cost IdentificationCost Categorisation, Cost Inclusion Decision
The process of determining which categories of resource use should be included in an economic evaluation before quantities and unit costs are measured.
Cost MeasurementCost Quantification, Resource Costing
The process of quantifying the resources consumed by a health intervention in monetary terms, forming the empirical foundation of economic evaluation.
Cost-Benefit AnalysisCBA, Benefit-Cost Analysis
Cost-benefit analysis is a full economic evaluation that values the differences in the costs and consequences of healthcare alternatives in monetary terms so that their net social value can be compared.
Cost-Utility AnalysisCUA, QALY-Based Cost-Effectiveness
Cost-utility analysis is a full economic evaluation that compares healthcare alternatives by relating differences in their costs to differences in preference-weighted health outcomes, most commonly quality-adjusted life years.
COVID EconomicsCOVID-19 Economics, Coronavirus Economics
The application of health economic evaluation to COVID-19, covering vaccination programmes, treatment strategies, and public health interventions such as testing.
CRE EconomicsCarbapenem-Resistant Enterobacteriaceae Economics, CRE Cost-Effectiveness
The application of health economic evaluation to carbapenem-resistant Enterobacteriaceae infections, a highly drug-resistant bacterial group posing a serious resistance threat.
Critical Care EconomicsIntensive Care Economics, ICU Economics
The application of health economic evaluation to intensive care unit treatment and staffing, an area marked by exceptionally high per-patient costs.
Crohn Disease EconomicsCrohn's Disease Economics, IBD Economics
The application of health economic evaluation to Crohn's disease, comparing conventional immunosuppressive therapy against newer, more targeted biologic treatments.
Cryptococcosis EconomicsCryptococcal Infection Economics, Cryptococcal Meningitis Economics
The application of health economic evaluation to cryptococcal fungal infections, which can cause severe illness particularly in immunocompromised patients such as those with advanced HIV.
CVD Diagnosis EconomicsCardiovascular Diagnosis Economics, CVD Diagnostic Cost-Effectiveness
The application of health economic evaluation to cardiovascular diagnostic strategies, comparing cost and accuracy across stress testing, imaging, and biomarker panels.
CVD Prevention EconomicsCardiovascular Prevention Economics, CVD Prevention Cost-Effectiveness
The application of health economic evaluation to cardiovascular disease prevention, spanning lifestyle programmes, preventive medication, and population health policy.
CVD Screening EconomicsCardiovascular Screening Economics, CVD Screening Cost-Effectiveness
The application of health economic evaluation to cardiovascular screening programmes for asymptomatic populations, accounting for both true and false test results.
CVD Treatment EconomicsCardiovascular Treatment Economics, CVD Therapy Cost-Effectiveness
The application of health economic evaluation to the full range of treatments for established cardiovascular disease, including medication, procedures, and surgery.

D

Decision Rule ApplicationRule Application, Threshold Application
The process of applying a predetermined criterion, such as a cost-effectiveness threshold, to an economic evaluation's results to reach a funding recommendation.
Defibrillator EconomicsICD Economics, ICD Cost-Effectiveness
The application of health economic evaluation to implantable cardioverter-defibrillators, weighing device and implant cost against preventing sudden cardiac death.
Delirium EconomicsDelirium Cost-Effectiveness, Acute Confusion Economics
The application of health economic evaluation to delirium, an acute confusion state common among hospitalised older adults, linked to complications and cognitive decline.
Dementia Care EconomicsDementia LTC Economics, Memory Care Economics
The application of health economic evaluation to long-term care for dementia, covering home support, day care, and residential memory care.
Dementia EconomicsDementia Cost-Effectiveness, Dementia HTA
The broad application of health economic evaluation to dementia, covering diagnosis, disease-modifying and symptomatic treatment, and long-term care.
Dengue EconomicsDengue Cost-Effectiveness, Dengue Fever Economics
The application of health economic evaluation to dengue fever, a mosquito-borne viral infection endemic to many tropical and subtropical regions.
Depression EconomicsDepression Cost-Effectiveness, Depression HTA
The application of health economic evaluation to depression, comparing psychotherapy, pharmacological treatment, and combination approaches across varying disease severity.
Dermatology EconomicsSkin Disease Economics, Economics of Dermatology
The broad application of health economic evaluation to skin conditions and treatment, covering both medical dermatology and skin cancer.
Diabetes EconomicsDiabetes Cost-Effectiveness, Diabetes HTA
The application of health economic evaluation to diabetes prevention, diagnosis, and management, spanning medication, monitoring technology, and complication prevention.
Dialysis EconomicsDialysis Cost-Effectiveness, Renal Replacement Economics
The application of health economic evaluation to dialysis for kidney failure, comparing haemodialysis and peritoneal dialysis modalities and treatment settings.
Differential DiscountingDifferential Discount Rates, Split-Rate Discounting
The practice of applying different discount rates to costs and health outcomes within an economic evaluation, rather than discounting both at the same rate.
Digital Health EconomicsDigital Health HTA, DHE
The application of health economic evaluation to digital health technologies, including mobile apps, remote monitoring, and software-based clinical decision support.
Diphtheria EconomicsDiphtheria Cost-Effectiveness, Diphtheria Vaccine Economics
The application of health economic evaluation to diphtheria, a serious bacterial infection largely controlled through routine childhood vaccination.
Discount Rate SelectionChoosing the Discount Rate, Rate Justification
The methodological decision on which discount rate to apply in an economic evaluation, informed by the social opportunity cost of capital and relevant guidance.
Discounting CostsCost Discounting, Present-Valuing Costs
The application of a discount rate to future costs within an economic evaluation, converting them into a common present-day value.
Discounting HealthHealth Outcome Discounting, Present-Valuing Benefits
The application of a discount rate to future health outcomes within an economic evaluation, converting them into a common present-day value.
Diverticulitis EconomicsDiverticulitis Cost-Effectiveness, Diverticular Disease Economics
The application of health economic evaluation to diverticulitis, comparing outpatient antibiotic management against hospitalisation and, in severe cases, surgery.